ghed by the disadvantages of its severe side effects ("The benefits," 1994, p. A1).
However, in another study of zidovudine, the findings were more positive. In fact, the study was halted because of these early positive findings. The objective of the study was to determine whether zidovudine was effective in reducing the rate of HIV transmission between infected mothers and infants. The findings showed that HIV transmission was reduced from 25.5 percent in pregnant women and their infants who received placebo to 8.3 percent in women and infants treated with zidovudine. The study concluded that this was the first drug ther
...